pharma news today obesity drugs glp-1 The Revolution: How Next-Generation Are Reshaping the Global Healthcare Market GLP-1s and the Unintended Consequences
Description
They are distinguished by their capability to produce elevated levels of pro-inflammatory cytokines, including IL-1, IL-6 and TNF- [79]
M.SvalastogaP.MaloneyK
A TD Cowen analyst said to Reuters that the current status quo lets compounders create copycat drugs if they make minor tweaks they claim benefit specific patient groups, leaving the door pretty wide open. All of this lands as Novo already faces pricing and patent pressure
The lawsuits allege inadequate warnings, not that the drugs should never have been approved
